
Chongqing Zhifei Biological Products Co., Ltd.
300122.SZFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
3,650
Cost of Revenue
2,656
Gross Profit
994
Gross Margin
27.2%
Operating Income
317
Operating Margin
8.7%
Net Income
283
Net Margin
7.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
379
EBITDA Margin
10.4%
2023
12/31/2023
Revenue
7,408
Cost of Revenue
5,458
Gross Profit
1,950
Gross Margin
26.3%
Operating Income
1,312
Operating Margin
17.7%
Net Income
1,130
Net Margin
15.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,333
EBITDA Margin
18.0%
2022
12/31/2022
Revenue
5,357
Cost of Revenue
3,573
Gross Profit
1,784
Gross Margin
33.3%
Operating Income
1,226
Operating Margin
22.9%
Net Income
1,055
Net Margin
19.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,260
EBITDA Margin
23.5%
2021
12/31/2021
Revenue
4,291
Cost of Revenue
2,202
Gross Profit
2,089
Gross Margin
48.7%
Operating Income
1,680
Operating Margin
39.1%
Net Income
1,429
Net Margin
33.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
1,722
EBITDA Margin
40.1%
2020
12/31/2020
Revenue
2,127
Cost of Revenue
1,304
Gross Profit
822
Gross Margin
38.7%
Operating Income
545
Operating Margin
25.6%
Net Income
462
Net Margin
21.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
579
EBITDA Margin
27.2%